Geode Capital Management, LLC Gossamer Bio, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,212,377 shares of GOSS stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,212,377

Previous 2,283,618 3.12%

Holding current value

$1.64 Million

Previous $2.06 Million 6.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.79 - $1.25 $56,280 - $89,051	-71,241 Reduced 3.12%	2,212,377 $2.19 Million
Q1 2024 May 13, 2024	BUY	$0.8 - $1.51 $8,554 - $16,146	10,693 Added 0.47%	2,283,618 $2.69 Million
Q4 2023 Feb 13, 2024	BUY	$0.48 - $1.08 $51,526 - $115,933	107,346 Added 4.96%	2,272,925 $2.07 Million
Q3 2023 Nov 13, 2023	BUY	$0.78 - $1.82 $1.09 Million - $2.54 Million	1,396,420 Added 181.55%	2,165,579 $1.8 Million
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.53 $565,558 - $882,963	-577,100 Reduced 42.87%	769,159 $922,000
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $49,099 - $149,343	51,145 Added 3.95%	1,346,259 $1.7 Million
Q4 2022 Feb 13, 2023	BUY	$1.74 - $12.87 $63,240 - $467,760	36,345 Added 2.89%	1,295,114 $2.81 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $1.68 Million - $3.46 Million	232,714 Added 22.68%	1,258,769 $15.1 Million
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $22,518 - $37,606	-3,772 Reduced 0.37%	1,026,055 $8.59 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $141,319 - $209,132	16,744 Added 1.65%	1,029,827 $8.94 Million
Q4 2021 Feb 11, 2022	BUY	$10.12 - $14.07 $175,298 - $243,720	17,322 Added 1.74%	1,013,083 $11.5 Million
Q3 2021 Nov 12, 2021	BUY	$7.25 - $13.23 $532,635 - $971,968	73,467 Added 7.97%	995,761 $12.5 Million
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $613,600 - $747,825	76,700 Added 9.07%	922,294 $7.49 Million
Q1 2021 May 12, 2021	BUY	$8.63 - $10.94 $591,992 - $750,451	68,597 Added 8.83%	845,594 $7.82 Million
Q4 2020 Feb 12, 2021	SELL	$8.3 - $13.59 $97,193 - $159,138	-11,710 Reduced 1.48%	776,997 $7.51 Million
Q3 2020 Nov 13, 2020	BUY	$11.3 - $14.75 $419,557 - $547,652	37,129 Added 4.94%	788,707 $9.79 Million
Q2 2020 Aug 13, 2020	BUY	$9.52 - $15.98 $1.52 Million - $2.56 Million	159,982 Added 27.04%	751,578 $9.77 Million
Q1 2020 May 14, 2020	BUY	$8.0 - $15.48 $513,528 - $993,676	64,191 Added 12.17%	591,596 $6 Million
Q4 2019 Feb 13, 2020	BUY	$14.82 - $26.79 $404,734 - $731,634	27,310 Added 5.46%	527,405 $8.24 Million
Q3 2019 Nov 12, 2019	BUY	$16.02 - $22.47 $4.12 Million - $5.78 Million	257,106 Added 105.81%	500,095 $8.4 Million
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $564,071 - $800,966	34,992 Added 16.82%	242,989 $5.39 Million
Q1 2019 May 14, 2019	BUY	$17.58 - $23.97 $3.66 Million - $4.99 Million	207,997 New	207,997 $4.51 Million

Others Institutions Holding GOSS

# of Institutions

108

Shares Held

167M

Call Options Held

430K

Put Options Held

519K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $69.5M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Gossamer Bio, Inc. Transaction History